Promoting liver health education. Our Passion is Prevention.
LHI WELCOMES DR. GISH TO THE TEAM
A warm and most enthusiastic welcome to Dr. Bob Gish for joining the Liver Health Initiative’s Advocates for Prevention Advisory Board of internationally revered leaders in academia and the medical community, dedicated to filling the enormous liver knowledge gap that underlies global epidemics of liver related diseases. Dr. Gish is well recognized for his passion, advocacy, patient and professional education and treatment in California and Nevada and also assisting with the development of healthcare policies both nationally and in several foreign countries.
In addition to being the current Adjunct Professor of Medicine at the University of Nevada Schools of Medicine in Las Vegas and in Reno, Dr. Gish serves as an Adjunct Professor of Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, and a Clinical Professor of Medicine at Loma Linda University. He has been involved in several research studies and has published over 700 original articles and book chapters.
Dr. Gish is also Medical Director of the Asia Pacific Health Foundation and of the Hepatitis B Foundation, and is seeing patients, both in-person and via telemedicine, at numerous clinics in southern California.
Having collaborated over many years, Thelma is delighted to have Dr. Gish join LHI'S team of Advocates for Prevention to help individuals understand why it is critically important to be tested and treated if infected to prevent the development of cirrhosis and eventually cancer.
Ultimately, with Dr. Gish on board, we are assured of success in providing the amazing liver its rightful place on the National Health Agenda. We have our work cut out for us. Glad to welcome Bob to the exciting challenge of promoting liver health education.
News From LHI
New Article: Yale Medicine's New Liver Disease Care Model Serves as Inspiration to Transform Prevention and Harm Reduction
September 21, 2022
Dr. Michael Houghton continues his conversation with ContagionLive, this time focusing on major goals for eliminating hepatitis C - all of which rely on promoting easily understandable and relatable liver health education.
September 7, 2022
Dr. Michael Houghton, LHI Board Member and Nobel Laureate was recently interviewed by ContagionLive about his journey to discovering the Hepatitis C virus, and current efforts to develop a preventative HCV vaccine.
September 6, 2022
"Our goal is to make liver health personal, relatable, and memorable so individuals are empowered to make better food and lifestyle choices."
~Thelma King Thiel, Cofounder & Chair
Learn about our passion for prevention and liver health education.
Teaching tools with memorable messages for children and adults.
Send us your feedback and suggestions.